Neuraxis Inc. (NRXS)
AMEX AMEX Primary Summary
NRXS Chart
NeurAxis Stock Down Following Q2 Earnings Despite Revenue Growth
NRXS reports strong second-quarter 2025 revenue growth and lower losses, but gross margin compression remains a key concern.
NeurAxis, Inc. (NRXS) Q2 2025 Earnings Call Transcript
NeurAxis, Inc. (NYSE:NRXS ) Q2 2025 Earnings Conference Call August 12, 2025 9:00 AM ET Company Participants Brian Carrico - President, CEO & Director Timothy Robert Henrichs - Chief Financial Officer Conference Call Participants Ben Shamsian - Unidentified Company Chase Richard Knickerbocker - Craig-Hallum Capital Group LLC, Research Division Lindsay Leeds - Unidentified Company Operator Good day, everyone, and welcome to the NeurAxis Report Second Quarter 2025 Financial Results. [Operator Instructions] Please note that this conference is being recorded.
NeurAxis Stock Gains Following Strong Q1 Earnings and FDA Milestones
NRXS posts strong first-quarter 2025 earnings with robust revenue growth and FDA milestones, driving stock gains as investors eye broader insurance coverage and market expansion.
Neuraxis Inc. Dividends
Neuraxis Inc. Earnings
| 24 Nov 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 18 Sep 2025 18 Sep 2025 Date | | - Cons. EPS | - EPS |
| 12 Aug 2025 Date | | - Cons. EPS | - EPS |
| 12 May 2025 Date | | - Cons. EPS | - EPS |
| 20 Mar 2025 Date | | - Cons. EPS | - EPS |
| 24 Nov 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
| 18 Sep 2025 18 Sep 2025 Date | | - Cons. EPS | - EPS |
| 12 Aug 2025 Date | | - Cons. EPS | - EPS |
| 12 May 2025 Date | | - Cons. EPS | - EPS |
| 20 Mar 2025 Date | | - Cons. EPS | - EPS |
Neuraxis Inc. (NRXS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Neuraxis Inc. ever had a stock split?
Neuraxis Inc. Profile
| Biotechnology Industry | Healthcare Sector | Mr. Brian Carrico CEO | AMEX Exchange | US64134X2018 ISIN |
| US Country | 19 Employees | - Last Dividend | - Last Split | 9 Aug 2023 IPO Date |
Overview
NeurAxis, Inc. is a pioneering medical technology enterprise focused on the innovation of neuromodulation therapies. These therapies are devised to alleviate chronic and debilitating conditions affecting both children and adults throughout the United States. Initially known as Innovative Health Solutions, Inc., the company underwent a name change to NeurAxis, Inc. in March 2022. Founded in 2011 and headquartered in Carmel, Indiana, NeurAxis, Inc. is at the forefront of offering groundbreaking solutions, significantly enhancing patient care. The company primarily caters to healthcare providers, including hospitals and clinics, distributing its technological advancements widely across the healthcare sector.
Products and Services
Listed below are the products and services offered by NeurAxis, Inc.:
- IB-Stim:
This is a cutting-edge percutaneous electrical nerve field stimulation system. It's specifically designed for use in younger patients, ranging from 11 to 18 years of age, who suffer from functional abdominal pain associated with irritable bowel syndrome (IBS). The system operates by delivering targeted electrical nerve field stimulation, providing a non-pharmacological treatment option that aims to significantly reduce the symptoms of IBS in this age group. By focusing on such a niche, NeurAxis, Inc. contributes to fulfilling a critical gap in pediatric healthcare solutions.
Contact Information
